Diagnostics & Research
The Diagnostics & Research industry has a total of 64 stocks, with a combined market cap of $716.67 billion, total revenue of $157.03 billion and a weighted average PE ratio of 50.58.
Market Cap
716.67B
Revenue
157.03B
Profits
14.17B
PE Ratio
50.58
Profit Margin
9.02%
Dividend Yield
0.22%
64 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 208.89B | -1.32% | 1,609,038 | 42.86B |
| 2 | DHR | Danaher Corporation | 177.28B | -0.40% | 2,931,216 | 23.89B |
| 3 | IQV | IQVIA Holdings Inc. | 41.36B | -0.82% | 704,490 | 14.98B |
| 4 | IDXX | IDEXX Laboratories, Inc. | 39.74B | -2.31% | 518,650 | 3.66B |
| 5 | A | Agilent Technologies, Inc. | 39.43B | -1.64% | 2,083,699 | 6.74B |
| 6 | MTD | Mettler-Toledo International Inc. | 25.62B | -2.46% | 146,522 | 3.79B |
| 7 | ICLR | ICON PLC | 24.09B | -0.68% | 378,390 | 8.12B |
| 8 | ILMN | Illumina, Inc. | 18.80B | 0.51% | 1,865,789 | 4.50B |
| 9 | WAT | Waters Corporation | 18.01B | -3.04% | 595,834 | 2.96B |
| 10 | LH | Laboratory Corporation of America Holdings | 16.82B | -0.97% | 649,777 | 12.16B |
| 11 | DGX | Quest Diagnostics Incorporated | 14.06B | -0.35% | 886,750 | 9.25B |
| 12 | RVTY | Revvity, Inc. | 12.42B | 0.27% | 755,322 | 2.75B |
| 13 | CRL | Charles River Laboratories International, Inc. | 11.82B | -0.97% | 448,841 | 4.13B |
| 14 | MEDP | Medpace Holdings, Inc. | 11.76B | -0.68% | 204,080 | 1.89B |
| 15 | EXAS | Exact Sciences Corporation | 11.48B | -1.00% | 2,516,188 | 2.50B |
| 16 | NTRA | Natera, Inc. | 10.76B | 0.01% | 678,921 | 1.08B |
| 17 | QGEN | Qiagen N.V. | 8.68B | -0.23% | 788,328 | 1.97B |
| 18 | RDNT | RadNet, Inc. | 3.49B | -0.19% | 393,939 | 1.62B |
| 19 | SHC | Sotera Health Company | 3.04B | -1.29% | 961,621 | 1.05B |
| 20 | OLK | Olink Holding AB (publ) | 2.77B | -1.63% | 645,627 | 169.60M |
| 21 | NEOG | Neogen Corporation | 2.63B | -0.16% | 3,140,988 | 929.24M |
| 22 | GH | Guardant Health, Inc. | 1.99B | 1.42% | 1,464,525 | 563.95M |
| 23 | NEO | NeoGenomics, Inc. | 1.75B | -1.23% | 561,430 | 591.64M |
| 24 | MYGN | Myriad Genetics, Inc. | 1.68B | -1.48% | 511,964 | 753.20M |
| 25 | TWST | Twist Bioscience Corporation | 1.63B | -0.14% | 808,782 | 262.36M |
| 26 | VCYT | Veracyte, Inc. | 1.42B | -0.32% | 619,589 | 361.05M |
| 27 | LAB | Standard BioTools Inc. | 999.76M | -3.69% | 3,702,723 | 106.34M |
| 28 | OPK | OPKO Health, Inc. | 871.24M | 3.31% | 4,729,765 | 863.50M |
| 29 | FLGT | Fulgent Genetics, Inc. | 598.38M | -3.04% | 215,021 | 289.21M |
| 30 | CSTL | Castle Biosciences, Inc. | 517.16M | -0.53% | 100,967 | 219.79M |
| 31 | CDNA | CareDx, Inc | 428.73M | 5.48% | 1,471,031 | 280.32M |
| 32 | SERA | Sera Prognostics, Inc. | 304.51M | -1.22% | 115,062 | 306.00K |
| 33 | ME | 23andMe Holding Co. | 172.01M | -8.69% | 6,139,132 | 247.99M |
| 34 | NOTV | Inotiv, Inc. | 139.79M | -3.56% | 319,739 | 585.17M |
| 35 | BDSX | Biodesix, Inc. | 138.34M | -3.20% | 38,236 | 49.09M |
| 36 | STIM | Neuronetics, Inc. | 117.83M | -1.98% | 23,739 | 71.35M |
| 37 | PRPH | ProPhase Labs, Inc. | 113.14M | -14.69% | 82,436 | 44.38M |
| 38 | FONR | FONAR Corporation | 104.53M | -1.61% | 15,532 | 102.42M |
| 39 | ACRS | Aclaris Therapeutics, Inc. | 87.24M | 0.82% | 535,331 | 31.25M |
| 40 | BNR | Burning Rock Biotech Limited | 82.11M | -4.76% | 4,308 | 75.80M |
| 41 | MDXH | MDxHealth SA | 62.76M | - | 42,624 | 70.19M |
| 42 | PSNL | Personalis, Inc. | 60.60M | -3.23% | 359,697 | 73.48M |
| 43 | ENZ | Enzo Biochem, Inc. | 58.91M | - | 123,970 | 12.81M |
| 44 | VNRX | VolitionRx Limited | 48.76M | -4.18% | 172,726 | 775.30K |
| 45 | AWH | Aspira Women's Health Inc. | 43.08M | 1.16% | 13,710 | 9.15M |
| 46 | PRE | Prenetics Global Limited | 38.21M | -1.87% | 77,282 | 21.74M |
| 47 | DRIO | DarioHealth Corp. | 35.63M | 2.54% | 57,728 | 20.35M |
| 48 | BIAF | bioAffinity Technologies, Inc. | 33.51M | 2.83% | 209,537 | 2.53M |
| 49 | XGN | Exagen Inc. | 24.13M | - | 3,813 | 52.55M |
| 50 | OCX | OncoCyte Corporation | 21.40M | -5.82% | 35,748 | 1.50M |
| 51 | DMTK | DermTech, Inc. | 20.50M | -3.63% | 169,052 | 15.30M |
| 52 | TTOO | T2 Biosystems, Inc. | 16.21M | -3.29% | 62,750 | 7.19M |
| 53 | MYNZ | Mainz Biomed B.V. | 15.60M | -3.76% | 22,572 | 895.48K |
| 54 | PMD | Psychemedics Corporation | 14.75M | - | 885 | 22.10M |
| 55 | TRIB | Trinity Biotech plc | 14.06M | -1.08% | 3,051 | 56.83M |
| 56 | STRR | Star Equity Holdings, Inc. | 13.95M | 0.58% | 4,690 | 45.79M |
| 57 | CNTG | Centogene N.V. | 13.38M | -0.02% | 17,457 | 55.72M |
| 58 | CHEK | Check-Cap Ltd. | 12.75M | -2.68% | 31,524 | - |
| 59 | GENE | Genetic Technologies Limited | 12.30M | -0.32% | 12,921 | 5.78M |
| 60 | PRPO | Precipio, Inc. | 9.21M | -0.37% | 785 | 15.20M |
| 61 | XWEL | XWELL, Inc. | 5.81M | 2.21% | 6,863 | 30.11M |
| 62 | APDN | Applied DNA Sciences, Inc. | 5.65M | -4.58% | 83,515 | 9.00M |
| 63 | NDRA | ENDRA Life Sciences Inc. | 2.55M | -15.70% | 288,472 | - |
| 64 | ISPC | iSpecimen Inc. | 1.94M | 0.42% | 240,678 | 9.93M |